Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure

Transplantation

Volumn 79, Issue 10, 2005, Pages 1378-1385

  Chen, Yong ^a   Kobayashi, Naoya ^a   Suzuki, Satoshi ^b   Soto Gutierrez, Alejandro ^a   Rivas Carrillo, Jorge David ^a   Tanaka, Kimiaki ^a   Navarro Alvarez, Nalú ^a   Fukazawa, Takuya ^a   Narushima, Michiki ^a   Miki, Atsushi ^a   Okitsu, Teru ^c   Amemiya, Hiroshi ^b   Tanaka, Noriaki ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b HAB Research Laboratories   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute liver failure; Hepatocyte; Hepatocyte growth factor

Indexed keywords

ALBUMIN; AMMONIA; BIOCHEMICAL MARKER; DIAZEPAM; GALACTOSAMINE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; LIDOCAINE; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GENETIC VARIABILITY; GRAFT SURVIVAL; HEMOFILTRATION; HISTOPATHOLOGY; LIVER CELL CULTURE; LIVER FAILURE; LIVER REGENERATION; LIVER TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE;

ALBUMINS; AMMONIA; ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIVISION; CHILD; DIAZEPAM; DNA-BINDING PROTEINS; FEMALE; GENE DELETION; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 4; HEPATOCYTES; HUMANS; LIDOCAINE; LIVER; LIVER FAILURE, ACUTE; MALE; MICE; MICE, SCID; MIDDLE AGED; PHOSPHOPROTEINS; SURVIVAL ANALYSIS; TISSUE CULTURE TECHNIQUES; TRANSCRIPTION FACTORS; TRANSPLANTATION, HETEROLOGOUS; VARIATION (GENETICS);

EID: 21144455177     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000160813.37515.97     Document Type: Article

References (30)

1. McHutchison JG. Understanding hepatitis C. Am J Manag Care 2004; 10: S21-S29.
2. Yano K, Yatsuhashi H, Yano M. Epidemiology of hepatitis C in Japan. Nippon Rinsho 2004; 62: 241-247.
3. Zhao S, Xu Z, Lu Y. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in China. Int J Epidemiol 2000; 29: 744-752.
4. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60-66.
5. Abe T, Kobata H, Hanba Y, et al. Study of plasma exchange for liver failure: beneficial and harmful effects. Ther Apher Dial 2004; 8: 180-184.
6. Gerlach JC, Mutig K, Sauer IM, et al. Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study. Transplantation 2003; 76: 781-786.
7. Demetriou AA, Brown RS Jr, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660-667.
8. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-443.
9. Pediaditakis P, Lopez-Talavera JC, Petersen B, et al. The processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the rat. Hepatology 2001; 34: 688-693.
10. Shima N, Tsuda E, Goto M, et al. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in their biological activity and tertiary structure. Biochem Biophys Res Commun 1994; 29: 808-815.
11. Kinoshita M, Yamaguchi K, Murakami A, et al. Analysis of deleted variant of hepatocyte growth factor by alanine scanning mutagenesis: identification of residues essential for its biological function and generation of mutants with enhanced mitogenic activity on rat hepatocytes. FEBS Lett 1998; 434: 165-170.
12. Kunieda T, Maruyama M, Okitsu T, et al. Cryopreservation of primarily isolated porcine hepatocytes with UW solution. Cell Transplant 2003; 12: 607-616.
13. Kobayashi N, Fujiwara T, Westerman KA, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000; 287: 1258-1262.
14. Ohtani S, Kagawa S, Tango Y, et al. Quantitative analysis of p53-trageted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo. Mol Cancer Ther 2004; 3: 93-100.
15. Kunieda T, Kobayashi N, Sakaguchi M, et al. Transduction of immortalized human hepatocytes with p21 to enhance differentiated phenotypes. Cell Transplant 2002; 11: 421-428.
16. Oh SH, Miyazaki M, Kouchi H, et al. Hepatocyte growth factor induces differentiation of adult rat bone marrow cells into a hepatic lineage in vitro. Biochem Biophys Res Com 2000; 279: 500-504.
17. Sachs M, Brohmann H, Zechner D, et al. Essential role of Gab1 for signaling by the c-Met receptor in vivo. J Cell Biol 2000; 150: 1375-1384.
18. Furge KA, Zhang YW, Vande Woude GF. Met receptor tyrosine kinase: enhanced signaling through adapter proteins. Oncogene 2000; 19: 5582-5589.
19. Potempa S, Ridley AJ. Activation of both MAP kinase and phosphatidylinositide 3-kinase by Ras is required for hepatocyte growth factor/scatter factor-induced adherens junction disassembly. Mol Biol Cell 1998; 9: 2185-2200.
20. Niranjan B, Buluwela L, Yant J, et al. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 1995; 121: 2897-2908.
21. Kobayashi N, Ito M, Nakamura J, et al. Hepatocyte transplantation in rat with decompensated cirrhosis. Hepatology 2000; 31: 851-857.
22. Guillouzo A, Morel F, Fardel O, et al. Use of human hepatocyte cultures for drug metabolism studies. Toxicology 1993; 82: 209-219.
23. Duncan SA, Navas MA, Dufort D, et al. Regulation of a transcription factor network required for differentiation and metabolism. Science 1998; 281: 692-695.
24. Runge D, Runge DM, Bowen WC, et al. Matrix induced re-differentiation of cultured rat hepatocytes and changes of CCAAT/enhancer binding proteins. Biol Chem 1997; 378: 873-881.
25. Runge D, Runge DM, Jager D, et al. Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functions. Biochem Biophys Res Commun 2000; 269: 46-53.
26. Hino H, Tateno C, Sato H, et al. A long-term culture of human hepatocytes which show a high growth potential and express their differentiated phenotypes. Biochem Biophys Res Commun 1999; 256: 184-191.
27. Chen HL, Wu HL, Fon CC, et al. Long-term culture of hepatocytes from human adults. J Biomed Sci 1998; 5: 435-440.
28. Gordon GJ, Butz GM, Grisham JW, et al. Isolation, short-term culture, and transplantation of small hepatocyte-like progenitor cells from retrorsine-exposed rats. Transplantation 2002; 73: 1236-1243.
29. Watanabe T, Shibata N, Westerman KA, et al. Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation 2003; 75: 1873-1880.
30. Hou DX, Arimura M, Fukuda M, et al. Expression of cell adhesion molecule and albumin genes in primary culture of rat hepatocytes. Cell Biol Int 2001; 25: 239-244.